45 results
8-K
EX-99.2
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
information, please see the PEMGARDA full product Fact Sheet for Healthcare Providers, including important safety information and boxed warning. 6
INVIVYD … IP major commercial payors authorized population WAC: Wholesale acquisition cost; HCPCS: Healthcare Common Procedure Coding System; CMS: U.S. Centers
8-K
EX-99.1
IVVD
Invivyd Inc
9 May 24
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
4:08pm
, Invivyd announced that CMS has granted a Healthcare Common Procedure Coding System (HCPCS) Q code (Q0224) covering product reimbursement … prophylaxis of COVID-19. Anaphylaxis has been observed with PEMGARDA and the PEMGARDA Fact Sheet for Healthcare Providers includes a boxed warning
8-K
EX-99.1
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
Sheet for Healthcare Providers includes a boxed warning for anaphylaxis. The most common adverse events (all grades, incidence ≥2%) observed … the PEMGARDA full product Fact Sheet for Healthcare Providers, including important safety information and boxed warning.
To support the EUA for PEMGARDA
8-K
EX-99.1
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
for Healthcare Providers includes a boxed warning for anaphylaxis. The most common adverse events (all grades, incidence ≥2%) observed in participants … the PEMGARDA full product Fact Sheet for Healthcare Providers, including important safety information and boxed warning.
To support the EUA for PEMGARDA
8-K
EX-99.2
rbnj0
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
EX-99.1
dp6f5 y1lgppfb9zaw5j
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
EX-99.1
r5h652y9jq7ize6fpwqu
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
EX-99.3
x33ik vuvnqssz
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
rezr68x09c18
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
EX-99.1
donz1raureyu 36p
8 Jan 24
Other Events
7:12am
8-K
EX-10.1
ufzqqzadiq taqzk
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
8-K
EX-99.1
mkyhk yji5jsajs9
10 Aug 23
Invivyd Reports Second Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
EX-99.1
ufg1yxaugrc
27 Jul 23
Invivyd Announces Appointment of Sara Cotter to Board of Directors
4:06pm
DEF 14A
yf5km7hz32argu1yh56
10 Apr 23
Definitive proxy
4:07pm
PRE 14A
gy3ad9toarn
31 Mar 23
Preliminary proxy
4:36pm
8-K
EX-99.1
pw7sxxpkb 3q5d78jn
24 Oct 22
Invivyd Announces the Appointment of Christine Lindenboom to Board of Directors
4:30pm